ArticleFrontiers in pharmacology2022

Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial.

Francesco Di Pierro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.